Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Treasury Shares (2016 - 2025)

Cross Country Healthcare's Treasury Shares history spans 15 years, with the latest figure at $564702.0 for Q4 2025.

  • For Q4 2025, Treasury Shares rose 37.83% year-over-year to $564702.0; the TTM value through Dec 2025 reached $564702.0, up 37.83%, while the annual FY2025 figure was $564702.0, 37.83% up from the prior year.
  • Treasury Shares reached $564702.0 in Q4 2025 per CCRN's latest filing, up from $293178.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.2 million in Q1 2021 to a low of $293178.0 in Q3 2025.
  • Average Treasury Shares over 5 years is $552684.0, with a median of $499126.0 recorded in 2021.
  • Peak YoY movement for Treasury Shares: skyrocketed 106.4% in 2021, then tumbled 47.36% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $522166.0 in 2021, then dropped by 8.82% to $476086.0 in 2022, then fell by 12.37% to $417197.0 in 2023, then dropped by 1.8% to $409698.0 in 2024, then surged by 37.83% to $564702.0 in 2025.
  • Per Business Quant, the three most recent readings for CCRN's Treasury Shares are $564702.0 (Q4 2025), $293178.0 (Q3 2025), and $297111.0 (Q2 2025).